Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Medicine Manufacturing	882.29M	838.96M	704.18M	616.38M	530.86M
Medicine Manufacturing Growth	5.16%	19.14%	14.25%	16.11%	14.45%
Site Lease Income	286.85K	303.87K	342.51K	331.66K	335.44K
Site Lease Income Growth	-5.60%	-11.28%	3.27%	-1.13%	38.39%
Total	882.57M	839.26M	704.53M	616.71M	531.20M
Total Growth	5.16%	19.12%	14.24%	16.10%	14.47%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Overseas	141.22M	100.76M	94.64M	63.54M	58.60M
Overseas Growth	40.16%	6.46%	48.96%	8.43%	31.00%
East China	343.11M	308.72M	264.34M	237.56M	193.12M
East China Growth	11.14%	16.79%	11.28%	23.01%	15.08%
Southern China	117.44M	111.46M	82.03M	75.41M	86.38M
Southern China Growth	5.36%	35.89%	8.78%	-12.71%	10.74%
North China, Northeast Region	112.17M	147.91M	132.47M	113.13M	92.31M
North China, Northeast Region Growth	-24.17%	11.66%	17.09%	22.56%	21.49%
Central China	95.09M	85.23M	71.53M	73.91M	60.95M
Central China Growth	11.58%	19.14%	-3.21%	21.26%	11.70%
Southwest and Northwest Region	73.54M	85.18M	59.51M	53.17M	39.85M
Southwest and Northwest Region Growth	-13.67%	43.13%	11.92%	33.44%	-7.29%
Total	882.57M	839.26M	704.53M	616.71M	531.20M
Total Growth	5.16%	19.12%	14.24%	16.10%	14.47%

Source: S&P Global Market Intelligence.